Autosomal dominant non-syndromic intellectual disability

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:178469OMIM:617796F71F72F73
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Autosomal dominant non-syndromic intellectual disability (also referred to as autosomal dominant mental retardation or ADID) is a group of genetically heterogeneous conditions characterized by significant limitations in intellectual functioning and adaptive behavior that arise during the developmental period, without the additional systemic features or recognizable physical patterns that define syndromic forms of intellectual disability. The condition is caused by heterozygous pathogenic variants in any of numerous genes, with many distinct genetic subtypes identified (designated MRD1 through MRD70+ in OMIM). These genes are involved in critical neurodevelopmental pathways including synaptic signaling, chromatin remodeling, and transcriptional regulation, primarily affecting the central nervous system. The core clinical feature is intellectual disability ranging from mild (ICD-10: F70) to profound (ICD-10: F73), manifesting as delays in cognitive development, speech and language acquisition, learning, and adaptive skills such as social functioning and daily living activities. By definition, the condition is non-syndromic, meaning that affected individuals do not have a consistent pattern of major congenital malformations, distinctive facial features, or multi-organ involvement, although minor or variable associated features such as behavioral difficulties, attention problems, or mild motor delays may sometimes be present. Onset is typically recognized in infancy or early childhood when developmental milestones are not met at expected ages. There is currently no cure or disease-specific pharmacological treatment for autosomal dominant non-syndromic intellectual disability. Management is supportive and multidisciplinary, focusing on early intervention programs, speech and language therapy, occupational therapy, special education services, and behavioral support. Genetic counseling is important for affected families, as the condition follows an autosomal dominant inheritance pattern, meaning each child of an affected individual has a 50% chance of inheriting the causative variant. However, many cases arise from de novo (new) mutations, with no prior family history of the condition.

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Autosomal dominant non-syndromic intellectual disability.

View clinical trials →

No actively recruiting trials found for Autosomal dominant non-syndromic intellectual disability at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Autosomal dominant non-syndromic intellectual disability community →

No specialists are currently listed for Autosomal dominant non-syndromic intellectual disability.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Autosomal dominant non-syndromic intellectual disability.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Autosomal dominant non-syndromic intellectual disabilityForum →

No community posts yet. Be the first to share your experience with Autosomal dominant non-syndromic intellectual disability.

Start the conversation →

Latest news about Autosomal dominant non-syndromic intellectual disability

2 articles
ResearchCONGRESSApr 1, 2026
AAN 2026: Social Determinants of Health, the Diagnostic Odyssey, and Genetic Testing for Global Developmental Delay/Intellectual Disability: A Qualitative Study.
Researchers studied how life circumstances like poverty, access to healthcare, and education affect children with developmental delays and intellectual disabili
Clinical trialCLINICALTRIALSMar 26, 2026
Trial Now Recruiting: Genome Medical Sequencing for Gene Discovery (NCT01087320)
Researchers are recruiting 2,000 people with rare genetic disorders to participate in a study using a new technology called genome sequencing. This technology r
See all news about Autosomal dominant non-syndromic intellectual disability

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Autosomal dominant non-syndromic intellectual disability

What is Autosomal dominant non-syndromic intellectual disability?

Autosomal dominant non-syndromic intellectual disability (also referred to as autosomal dominant mental retardation or ADID) is a group of genetically heterogeneous conditions characterized by significant limitations in intellectual functioning and adaptive behavior that arise during the developmental period, without the additional systemic features or recognizable physical patterns that define syndromic forms of intellectual disability. The condition is caused by heterozygous pathogenic variants in any of numerous genes, with many distinct genetic subtypes identified (designated MRD1 through

How is Autosomal dominant non-syndromic intellectual disability inherited?

Autosomal dominant non-syndromic intellectual disability follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Autosomal dominant non-syndromic intellectual disability typically begin?

Typical onset of Autosomal dominant non-syndromic intellectual disability is infantile. Age of onset can vary across affected individuals.